Case Studies

Through a board member recommendation, Cilatus was asked by the CEO of a late-stage, US West Coast based, publicly listed Biopharmaceutical Company to assess…

For one of our first clients, Cilatus performed as the external, «Virtual CMC» development, CMC regulatory affairs and quality assurance team. Our US-based, NASDAQ…

Most of our clients work with CDMO’s and CMO’s in the early development stages. As one Biologic client progressed into late-stage development and potential…

On recommendation, Cilatus was asked by a Chinese biopharmaceutical company to support their process characterization and validation effort. Cilatus analyzed all development work done…

A few years ago, Cilatus was asked to perform CMC due diligence for two private equity investment companies who wanted to invest in a…